Table 2.
Variables | Objective Binge-Eating Episodes (Yes vs. No) | Purging Behaviors (Yes vs. No) | |||||
---|---|---|---|---|---|---|---|
t or χ2 | p | q-FDR | t or χ2 | p | q-FDR | ||
Age | 0.095 | <0.001 | 0.004 | 2.165 | 0.099 | 0.040 | |
Gender | Male | 1.893 | 0.169 | 0.043 | 0.397 | 0.529 | 0.061 |
Female | |||||||
Education (years) | 0.285 | 0.360 | 0.054 | 1.216 | 0.228 | 0.052 | |
Work | Unemployed | 1.328 | 0.580 | 0.074 | 7.072 | 0.029 | 0.016 |
Student | |||||||
Employed | |||||||
Marital Status Missing n = 4 |
Single/separated | 0.038 | 0.846 | 0.093 | 0.201 | 0.654 | 0.072 |
Married | |||||||
Smoke Missing n = 3 |
No | 0.051 | 0.822 | 0.090 | 0.432 | 0.511 | 0.058 |
Yes | |||||||
Number of cigarettes/day Missing n = 3 |
0.046 | 0.873 | 0.088 | 1.061 | 0.030 | 0.032 | |
Dietary habits Missing n = 4 |
Omnivorous | 6.574 | 0.087 | 0.032 | 2.820 | 0.420 | 0.051 |
Vegetarian | |||||||
Hyperproteic | |||||||
Age at onset | 1.151 | 0.808 | 0.085 | 2.721 | 0.015 | 0.024 | |
Diagnosis | AN | 26.693 | <0.001 | 0.002 | 10.186 | 0.017 | 0.015 |
BN | |||||||
BED | |||||||
OSFED | |||||||
Duration of illness (months) | 2.162 | 0.019 | 0.031 | 0.842 | 0.273 | 0.056 | |
DUI (months) | 0.823 | 0.114 | 0.038 | 1.672 | 0.019 | 0.028 | |
BMI | 4.422 | 0.245 | 0.046 | 2.173 | <0.001 | 0.004 | |
Family history of mental disorders Missing n = 2 |
No | 0.993 | 0.319 | 0.061 | 0.214 | 0.644 | 0.070 |
Yes | |||||||
Type of family history Missing n = 2 |
None | 5.619 | 0.229 | 0.052 | 4.016 | 0.404 | 0.048 |
Major depression | |||||||
Anxiety disorders | |||||||
SUD | |||||||
EDs | |||||||
Obstetrical complications | None | 3.715 | 0.294 | 0.058 | 4.003 | 0.261 | 0.032 |
Low weight (<2500 g) | |||||||
Premature (<32 weeks) | |||||||
Cord hypoxia | |||||||
Lifetime substance use disorders Missing n = 1 |
No | 1.389 | 0.239 | 0.053 | 1.745 | 0.187 | 0.028 |
Yes | |||||||
Main type of substance use disorder Missing n = 1 |
None | 6.597 | 0.159 | 0.040 | 4.950 | 0.292 | 0.037 |
Cannabinoids | |||||||
Opioids | |||||||
Cocaine | |||||||
Alcohol | |||||||
Poly-substance use disorders Missing n = 1 |
No | 3.704 | 0.054 | 0.026 | 0.003 | 0.954 | 0.094 |
Yes | |||||||
Psychiatric comorbidity Missing n = 2 |
No | 5.628 | 0.018 | 0.012 | 0.783 | 0.376 | 0.045 |
Yes | |||||||
Type of psychiatric comorbidity Missing n = 2 |
None | 11.642 | 0.009 | 0.007 | 3.035 | 0.386 | 0.046 |
Major depression | |||||||
Anxiety disorders | |||||||
OCD | |||||||
Multiple psychiatric comorbidity Missing n = 2 |
No | - | - | - | - | - | - |
Lifetime psychotic symptoms Missing n = 1 |
No | - | - | - | - | - | - |
Personality disorder Missing n = 6 |
No | 6.016 | 0.014 | 0.010 | 0.621 | 0.431 | 0.053 |
Yes | |||||||
Type of personality disorder Missing n = 6 |
None | 11.042 | 0.026 | 0.018 | 5.108 | 0.276 | 0.035 |
Schizotypic | |||||||
Borderline | |||||||
Hystrionic | |||||||
Obsessive–compulsive | |||||||
Lifetime suicide attempts | No | - | - | - | - | - | - |
Lifetime hospitalizations Missing n = 4 |
No | 0.330 | 0.566 | 0.075 | 1.084 | 0.298 | 0.039 |
Yes | |||||||
Number of hospitalizations | 1.301 | 0.012 | 0.023 | 0.536 | 0.385 | 0.060 | |
Current pharmacological treatment | No | 2.350 | 0.125 | 0.037 | 0.047 | 0.828 | 0.084 |
Yes | |||||||
Main current pharmacological treatment Missing n = 1 |
None | 7.804 | 0.453 | 0.068 | 5.623 | 0.689 | 0.075 |
Sertraline | |||||||
Escitalopram | |||||||
Vortioxetine | |||||||
Olanzapine | |||||||
Benzodiazepines | |||||||
Pregabalin | |||||||
Fluoxetine | |||||||
Melatonine | |||||||
Current poly-therapy Missing n = 1 |
No | 2.568 | 0.109 | 0.034 | 0.321 | 0.571 | 0.064 |
Yes | |||||||
Current psychotherapy Missing n = 1 |
No | 0.496 | 0.481 | 0.069 | 0.024 | 0.877 | 0.089 |
Yes | |||||||
Pharmacotherapy prescription | No | 7.864 | 0.005 | 0.005 | 0.158 | 0.691 | 0.076 |
Yes | |||||||
Type of pharmacotherapy prescription Missing n = 2 |
None | 12.704 | 0.048 | 0.024 | 3.474 | 0.747 | 0.080 |
Sertraline | |||||||
Escitalopram | |||||||
Vortioxetine | |||||||
Zolpidem | |||||||
Benzodiazepine | |||||||
Pregabalin | |||||||
Duration of the last pharmacological treatment (months) | 3.189 | <0.001 | 0.011 | 0.311 | 0.489 | 0.076 | |
Medical comorbidity Missing n = 3 |
No | 1.002 | 0.317 | 0.061 | 0.674 | 0.412 | 0.050 |
Yes | |||||||
Thyroid disorders Missing n = 3 |
No | 1.559 | 0.212 | 0.047 | 1.110 | 0.292 | 0.036 |
Yes | |||||||
Hypercholesterolemia Missing n = 2 |
No | 1.758 | 0.185 | 0.045 | 1.063 | 0.302 | 0.040 |
Yes | |||||||
Diabetes Missing n = 1 |
No | - | - | - | - | - | - |
Multiple medical comorbidities Missing n = 1 |
No | 1.277 | 0.258 | 0.057 | 1.923 | 0.166 | 0.024 |
Yes | |||||||
Amenorrhea Missing n = 3 |
No | 5.032 | 0.081 | 0.030 | 7.821 | 0.020 | 0.015 |
Yes | |||||||
Estroprogestinic therapy | |||||||
Self-induced vomiting | No | 4.703 | 0.030 | 0.019 | 20.433 | <0.001 | 0.003 |
Yes | |||||||
Number of episodes of self-induced vomiting acts in the last month | 2.675 | <0.001 | 0.015 | 2.380 | <0.001 | 0.012 | |
Laxative misuse | No | 0.242 | 0.623 | 0.078 | 10.508 | 0.001 | 0.009 |
Yes | |||||||
Number of episodes of laxative use in the last month | 0.346 | 0.612 | 0.065 | 2.014 | <0.001 | 0.016 | |
Diuretic misuse | No | 0.145 | 0.704 | 0.084 | 2.002 | 0.157 | 0.023 |
Yes | |||||||
Number of episodes of diuretic use in the last month | 0.424 | 0.398 | 0.058 | 1.414 | 0.003 | 0.020 | |
Compulsive exercise | No | 0.011 | 0.917 | 0.097 | 16.776 | <0.001 | 0.006 |
Yes | |||||||
Number of episodes of compulsive exercises in the last month | 1.212 | 0.004 | 0.019 | 4.084 | <0.001 | 0.008 | |
Number of objective binge-eating episodes in the last month | 5.895 | <0.001 | 0.008 | 0.700 | 0.180 | 0.044 | |
Number of subjective binge-eating episodes in the last month | 1.296 | 0.012 | 0.027 | 0.470 | 0.216 | 0.048 | |
Number of objective overeatings in the last month | 1.162 | 0.026 | 0.035 | 0.435 | 0.395 | 0.068 | |
Dietary restraint (EDE subscale) | 0.400 | 0.777 | 0.081 | 0.443 | 0.558 | 0.080 | |
Eating concern (EDE subscale) | 1.360 | 0.651 | 0.069 | 0.475 | 0.453 | 0.072 | |
Body shape concern (EDE subscale) | 2.146 | 0.774 | 0.077 | 0.013 | 0.874 | 0.100 | |
Weight concern (EDE subscale) | 2.297 | 0.149 | 0.042 | 0.397 | 0.799 | 0.092 | |
EDE global score | 1.295 | 0.533 | 0.061 | 0.189 | 0.662 | 0.084 | |
HAM-D | 1.449 | 0.302 | 0.050 | 0.502 | 0.870 | 0.096 | |
HAM-A | 2.122 | 0.966 | 0.100 | 0.201 | 0.754 | 0.088 | |
MADRS | 1.125 | 0.754 | 0.073 | 0.491 | 0.385 | 0.064 | |
CGI-S | 0.261 | 0.923 | 0.096 | 1.531 | 0.037 | 0.036 |
Legend: AN = anorexia nervosa; BED = binge-eating disorder; BMI = body mass index; BN = bulimia nervosa; CGI-S = Clinical Global Impression-severity subscale; χ2 = chi-square; DUI = duration of untreated illness; ED = eating disorder; EDE = Eating Disorder Examination; HAM-A = Hamilton Anxiety Rating Scale; HAM-D = Hamilton Depression Rating Scale; MADRS = Montgomery and Åsberg Depression Rating Scale; OCD = obsessive–compulsive disorder; OSFED = otherwise specified feeding and eating disorders; p = p-value; SUD = substance use disorder; t = Student’s t-test. In bold, statistically significant p-value (≤0.05). For the total, sample mean and ±standard deviations (into bracket) are reported for continuous variables and frequencies with percentages (into brackets) for qualitative variables. We have reported in bold statistically significant p and q-FDR values resulting from multiple comparison methods based on Benjamini–Hochberg False Discovery Rate.